Vnitr Lek 2009, 55(11):1097-1101

Recurrent unsustained ventricular tachycardia in pregnancy

K. Prymusová*, O. Ludka, V. Musil, J. ©pinar
Interní kardiologická klinika Lékařské fakulty MU a FN Brno, pracoviątě Bohunice, přednosta prof. MUDr. Jindřich ©pinar, CSc., FESC

The incidence of arrhythmias in pregnancy is more frequent. Arrhythmias can develop in women with structural heart disease as well as in healthy population. Palpitations, dizziness, vertigo or syncope are the most common symptoms of arrhythmias. Rarely life threatening arrhythmias requiring acute therapy occur. The treatment of the pregnant patient with cardiac arrhythmias requires important modifications of the standard practice. We describe pregnant patient in 33rd week of pregnancy with new onset of recurrent unsustained ventricular tachycardia, which did not regress after the pharmacological therapy. Patient was indicated to cesarean section, after which the arrhythmias completely regressed.

Keywords: arrhythmias; pregnancy

Received: March 3, 2009; Accepted: May 18, 2009; Published: November 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Prymusová K, Ludka O, Musil V, ©pinar J. Recurrent unsustained ventricular tachycardia in pregnancy. Vnitr Lek. 2009;55(11):1097-1101.
Download citation

References

  1. Tan HL, Lie KI. Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J 2001; 22: 458-464. Go to original source... Go to PubMed...
  2. Hameed A, Karaalp IS, Tummala PP et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001; 37: 893-899. Go to original source... Go to PubMed...
  3. Brodsky M, Doria R, Allen B et al. New-onset ventricular tachycardia during pregnancy. Am Heart J 1992; 123: 933-941. Go to original source... Go to PubMed...
  4. Shotan A, Ostrzega E, Mehra A et al. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness and syncope. Am J Cardiol 1997; 79: 1061-1064. Go to original source... Go to PubMed...
  5. Lee SH, Chen SA, Wu TJ et al. Effect of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. Am J Cardiol 1995; 76: 675-678. Go to original source... Go to PubMed...
  6. Nakagawa M, Katou S, Ichinose M et al. Characteristics of new-onset ventricular arrhythmias in pregnancy. J Electrocardiol 2004; 37: 47-53. Go to original source... Go to PubMed...
  7. Lydakis C, Lip G, Beevers M et al. Atenolol and fetal growth in pregnancy complicated by hypertension. Am J Hypertens 1999; 12: 541-547. Go to original source... Go to PubMed...
  8. Frishman W, Chesner M. Beta-adrenergic blockers in pregnancy. Am Heart J 1988; 115: 147-152. Go to original source... Go to PubMed...
  9. Chan V, Tse T, Wong V. Transfer of digoxin across 23 the placenta and into breast milk. Br J Obstet Gynaecol 1978; 85: 605-609. Go to original source... Go to PubMed...
  10. Kautzner J, Byteąník J, Čihák R. Arytmie. In: Aschermann M et al (eds). Kardiologie. Praha: Galén 2007: 1126-1146.
  11. Belhassen B, Shapira I, Pelleg A et al. Idiopathic recurrent sustained ventricular tachycardia responsive to verapamil: an ECG-electrophysiologic entity. Am Heart J 1984; 108: 1034-1037. Go to original source... Go to PubMed...
  12. Page RL, Shenasa H, Evans JJ et al. Radiofrequency catheter ablation of idiopathic recurrent ventricular tachycardia with right-bundle branch block, left axis morphology. Pacing Clin Electrophysiol 1993; 16: 327-336. Go to original source... Go to PubMed...
  13. Roden DM, Lazzara R, Rosen M et al. Multiple mechanisms in the long QT syndrome: current knowledge, gaps and future directions. Circulation 1996; 94: 1996-2012. Go to original source... Go to PubMed...
  14. Finlay AY, Edmunds V. DC cardioversion in pregnancy. Br J Clin Pract 1979; 33: 88-94. Go to original source... Go to PubMed...
  15. Joglar JA, Page RL. Antiarrhythmic drugs in pregnancy. Curr Opin Cardiol 2001; 16: 40-45. Go to original source... Go to PubMed...
  16. Cardosi RJ, Chez RA. Magnesium sulfate, maternal hypothermia and fetal bradycardia with loss of heart rate variability. Obstet Gynecol 1998; 92: 691-693. Go to original source... Go to PubMed...
  17. Varon ME, Sherer DM, Abramowicz JS et al. Maternal ventricular tachycardia associated with hypomagnesaemia. Am J Obstet Gynecol 1992; 167: 1352-1355. Go to original source... Go to PubMed...
  18. Widerhorn J, Bhandari AK, Bughi S et al. Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy. Am Heart J 1991; 122: 1162-1166. Go to original source... Go to PubMed...
  19. Magee LA, Downar E, Sermer M et al. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 1995; 172: 1307-1311. Go to original source... Go to PubMed...
  20. Janků K, Srp B. Problematika závaľných kardiovaskulárních chorob v těhotenství. Česk Gynekol 1993; 58 (Suppl): 38-43. Go to PubMed...
  21. Chaloupka V, Nekvasil R, Janků K et al. Některé problémy mladistvých s kardioangiopatiemi v souvislosti se stavem těhotenství. Vnitř Lék 1982; 28: 882-887. Go to PubMed...
  22. Janků K, Martinčík J, Pilka L. Příspěvek k problematice peripartální srdeční nemoci. Vnitř Lék 1977; 23: 1173-1177. Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.